Trovagene Inc (NASDAQ:TROV) shares traded -9.79% down during most recent session to reach at the closing price of $3.87. The stock exchanged hands 667255 shares versus average trading capacity of 721.73 Million shares, yielding a market cap of $14.89 Million. Wall Street analysts covering the stock are projecting that the stock will reach $14 within the next 52-weeks. The mean target projections are based on 2 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Trovagene Inc (NASDAQ:TROV) high price target of $20 and with a conservative view have low price target of $8.

Noble Financial “Reiterates” Trovagene Inc (NASDAQ:TROV) in a research note issued to investors on 3/08/19 to Outperform with price target of $20.

Additionally on 6/15/18 Maxim Group “Upgrades” Trovagene Inc (NASDAQ:TROV) to Buy setting price target at $0 and on 11/10/17 Maxim Group “Downgrades” the stock to Hold. Furthermore on 3/16/17 PiperJaffray “Downgrades” the stock to Underweight.

On the other hand the company has Relative Strength Index (RSI 14) of 53.88 along with Average True Range (ATR 14) of 0.78, Consequently Trovagene Inc (NASDAQ:TROV)’s weekly and monthly volatility is 35.23%, 19.46% respectively. The company’s beta value is at 0.61.

In terms of Buy, Sell or Hold recommendations, Trovagene Inc (NASDAQ:TROV) has analysts’ mean recommendation of 2. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Trovagene Inc (NASDAQ:TROV)’s minimum EPS for the current quarter is at $-1.07 and can go high up to $-1.07. The consensus mean EPS for the current quarter is at $-1.07 derived from a total of 1 estimates from the analysts who have weighed in on projected earnings. However the company reported $-6.48 earnings per share for the same quarter during last year.

Previously Trovagene Inc (NASDAQ:TROV) reported $-1.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $-1.05 by $-0.04. The company posted an earnings surprise of -3.8%.

Trovagene Inc (NASDAQ:TROV)’s revenue estimates for the current quarter are $170 Million according to 1 number of analysts, for the current quarter the company has high revenue estimates of $170 Million in contradiction of low revenue estimates of $170 Million. For the current year the company’s revenue estimates are $580 Million compared to low analyst estimates of $410 Million and high estimates of $750 Million according to 2 number of analysts.

Currently Trovagene Inc (NASDAQ:TROV)’s shares owned by insiders are 0.1%, whereas shares owned by institutional owners are 10.8%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 4%.

Trovagene Inc (NASDAQ:TROV)’s trailing twelve month revenues are $500000, whereas its price to sales ratio for the same period is 29.78. Its book value per share for the most recent quarter is $2.62 while its price to book ratio for the same period is 1.48, as for as the company’s cash per share for the most recent quarter is $0, however its price to cash per share ratio for the same period is 0. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.